Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074216 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Levels in Stage IV Colorectal Cancer Patients
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01074216: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01074216 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01074216, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects, good and/or bad, vitamin D blood levels has on stage IV colorectal cancer. Tbe doctors want to see if it is possible to increase low vitamin D levels into normal range using vitamin D supplements taken by mouth. Low vitamin D levels have been associated with worse outcomes in persons who have cancer. Low vitamin D may also cause people to have symptoms such as pain and fatigue. We want to see if increasing low vitamin D levels will help improve cancer outcomes. Vitamin D is routinely repleted in all subjects known to be vitamin D deficient. Therefore, the treatment given would be considered standard of care.
Interventions
- DRUG vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01074216
The ClinicalTrials.gov registry entry for NCT01074216 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units) is the first listed.
NCT01074216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01074216 about?
NCT01074216 is a clinical study titled "Vitamin D Levels in Stage IV Colorectal Cancer Patients". The purpose of this study is to find out what effects, good and/or bad, vitamin D blood levels has on stage IV colorectal cancer. Tbe doctors want to see if it is possible to increase low vitamin D levels into normal range using vitamin D supplements taken by mouth. Low vitamin D levels have been as...
What is the current status of trial NCT01074216?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2010-02. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01074216?
The interventions under investigation include: vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units) (DRUG).
Who is sponsoring clinical trial NCT01074216?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.